Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis

NCT02930044 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Maryland, Baltimore